Internal Medicine, Cardiovascular Disease · Chesterfield, MO
NPI
1598783938
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
121 Saint Lukes Center Dr, Ste 303
Chesterfield, MO, 63017
Phone (314) 434-3278
Groups this clinician bills Medicare through
Medicare paid, 2024
$202K
2,738 services
Medicare patients, 2024
1,042
Average age 76
Drug cost, 2024
$4.1M
14,907 prescriptions
Company payments, 2025
$2,414
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Keith Mankowitz was code 99214 (office e&m - established), 1,357 times for 883 patients. In total Keith Mankowitz billed 2,738 services in 24 codes, and Medicare paid $202K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,357 | 883 | $85.99 | $117K |
| 99233 Hospital E&M - Subsequent | Facility | 464 | 123 | $89.99 | $42K |
| 93000 Electrocardiogram | Office | 409 | 291 | $9.80 | $4,008 |
| 99204 Office E&M - New | Office | 107 | 107 | $109.61 | $12K |
| 99222 Hospital E&M - Initial | Facility | 70 | 59 | $99.40 | $6,958 |
| 92960 Cardiovascular | Facility | 50 | 35 | $78.63 | $3,931 |
| 99152 Anesthesia | Facility | 50 | 35 | $9.13 | $456 |
| 99215 Office E&M - Established | Office | 42 | 28 | $120.71 | $5,070 |
| 99213 Office E&M - Established | Office | 22 | 21 | $51.12 | $1,125 |
| 99232 Hospital E&M - Subsequent | Facility | 22 | 13 | $57.74 | $1,270 |
| 99214 Office E&M - Established | Facility | 18 | 17 | $70.40 | $1,267 |
| 99215 Office E&M - Established | Facility | 17 | 14 | $110.71 | $1,882 |
| 93325 Echocardiography (TTE/TEE) | Facility | 15 | 15 | $2.33 | $34.89 |
| 93320 Echocardiography (TTE/TEE) | Facility | 15 | 15 | $13.44 | $202 |
| 93312 Echocardiography (TTE/TEE) | Facility | 15 | 15 | $79.58 | $1,194 |
By year: 2022 $179K for 2,490 services; 2023 $184K for 2,381 services; 2024 $202K for 2,738 services.
Medicare prescription drug claims, 2024
In 2024, the drug Keith Mankowitz prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,170 prescriptions and refills. In total Keith Mankowitz wrote 14,907 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,170 | 3,217 | 344 | $10K |
| Eliquis Apixaban | 1,118 | 1,897 | 229 | $1.1M |
| Metoprolol Succinate Generic | 999 | 2,724 | 325 | $14K |
| Potassium Chloride Generic | 704 | 1,660 | 233 | $15K |
| Carvedilol Generic | 641 | 1,782 | 189 | $4,890 |
| Spironolactone Generic | 576 | 1,560 | 192 | $4,712 |
| Rosuvastatin Calcium Generic | 560 | 1,489 | 174 | $6,298 |
| Amlodipine Besylate Generic | 524 | 1,399 | 154 | $3,478 |
| Furosemide Generic | 508 | 1,200 | 178 | $2,252 |
| Metoprolol Tartrate Generic | 445 | 1,125 | 137 | $2,675 |
| Entresto Sacubitril/Valsartan | 422 | 727 | 99 | $458K |
| Losartan Potassium Generic | 364 | 1,000 | 119 | $3,148 |
| Ezetimibe Generic | 349 | 1,004 | 120 | $8,300 |
| Nitroglycerin Patch Nitroglycerin | 348 | 575 | 125 | $14K |
| Lisinopril Generic | 344 | 915 | 102 | $2,068 |
Brand drugs: - claims; generic drugs: 11,460 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Keith Mankowitz $2,414 ($2,414 in general payments such as food, travel and fees) from 24 companies. The largest payer was Boston Scientific Corporation with $338.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 12 | $338 |
| Novartis Pharmaceuticals Corporation NVS | 26 | $245 |
| Novo Nordisk Inc NVO | 16 | $197 |
| Amgen Inc. AMGN | 14 | $196 |
| Pfizer Inc. PFE | 11 | $180 |
| American Regent | 2 | $175 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $158 |
| Esperion Therapeutics, Inc. ESPR | 13 | $137 |
| Merck Sharp & Dohme LLC MRK | 6 | $103 |
| BridgeBio Pharma, Inc. BBIO | 4 | $89.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.